Outcome
    Moderate Evidence

    Rhodiola Rosea for Endurance Enhancement

    Acute rhodiola dosing improved time-to-exhaustion in a few small trials, but chronic supplementation has not shown reproducible performance gains.

    Overview

    Acute rhodiola dosing improved time-to-exhaustion in a few small trials, but chronic supplementation has not shown reproducible performance gains.

    Verdict

    Mixed evidence

    How It Works

    Rosavins and salidroside are proposed to enhance ATP resynthesis in mitochondria and reduce perceived exertion through central monoaminergic modulation.

    Dosing & Protocol

    Typical dose

    Recommended dose
    200-600 mg/day of Rhodiola rosea extract standardised to 3% rosavins and 1% salidroside, or 200 mg acutely 60 minutes before exercise
    Expected timeframe
    Acute, within 60 minutes

    Protocol

    form
    Rhodiola rosea root extract standardised to 3% rosavins and 1% salidroside
    duration
    Acute effects within 60 minutes in the positive trials; chronic dosing over 4 weeks showed less
    co factor
    Take on an empty stomach, 60 minutes before exercise for acute use. Evidence is mixed, with an unusual pattern. De Bock and colleagues found a single 200 mg dose improved time to exhaustion and maximal oxygen uptake in a crossover trial, while 4 weeks of daily supplementation in the same study produced no improvement - suggesting acute rather than chronic benefit, and possibly tolerance. Noreen found a single 3 mg/kg dose improved 6-mile time trial performance and reduced perceived exertion. Other trials show no effect on endurance measures. The mechanism proposed is reduced perception of effort rather than a change in physiological capacity.
    titration
    Up to 600 mg/day for chronic use; the acute studies used single doses of 200-3 mg/kg
    starting dose
    200 mg once daily in the morning, or a single 200 mg dose 60 minutes before a session for acute use

    Evidence

    What the studies say

    A small acute-dosing trial showed improved endurance capacity and lower perceived exertion, while follow-up chronic-dosing studies were null. Sample sizes under 30 and inconsistent extract standardisation limit confidence.

    Rhodiola rosea supplementation on sports performance: a systematic review of randomized controlled trials

    Score: 8/10
    2023
    systematic_review
    n=263

    Sanz-Barrio PM, Noreen EE, Gilsanz-Estebaranz L +3 more

    The results were heterogenous, having 11 studies with some positive effects, while 2 studies show no effect in variables such as rating of perceive exertion, heart rate, antioxidant capacity, blood lactate, creatine kinase, or C-reactive protein.

    View source

    The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials

    Score: 8/10
    2011
    systematic_review

    Hung SK, Perry R, Ernst E

    R. rosea may have beneficial effects on physical performance, mental performance and certain mental health conditions.

    View source

    Rhodiola rosea for physical and mental fatigue: a systematic review

    Score: 9/10
    2012
    systematic_review

    Ishaque S, Shamseer L, Bukutu C +1 more

    Two of six trials examining physical fatigue in healthy populations report R. rosea to be effective as did three of five RCTs evaluating R. rosea for mental fatigue.

    View source

    Safety

    Caveats

    The evidence pattern here is unusual and worth respecting: acute dosing helped in a couple of small trials, four weeks of daily use did not, and the effect appears to be on perceived exertion rather than physiological capacity. That means the ceiling is low and the mechanism is partly psychological. Training, periodisation, carbohydrate availability, iron status, sleep and heat and altitude acclimatisation move endurance far more, and caffeine has vastly better evidence for acute performance. Safety of rhodiola: generally well tolerated, with dizziness, dry mouth, irritability and insomnia; doses above 600 mg/day are not well studied. Avoid evening dosing because it is activating - a real issue for athletes with evening sessions and early races. Avoid in bipolar disorder because of activation and possible mania. Theoretical interactions with MAO inhibitors, SSRIs and other serotonergic medication, and possible CYP3A4 and P-glycoprotein inhibition. Rhodiola is not currently on the WADA prohibited list, but supplement contamination is a real risk for tested athletes - use batch-tested products only. Adulteration with cheaper Rhodiola species is common. Avoid in pregnancy and breastfeeding.

    Less likely to help if

    Well-trained athletes, and anyone using chronic daily dosing, which did not improve endurance.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.